Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Myeloid Leukaemias (AML)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04589728
What this trial is testing

Prospective and Retrospective Observational Evaluation of Real World Outcome of Unfit AML Patients Treated With the Combination Venetoclax Plus Hypomethylating Agents, Under the Italian Law No.648/96

Who this might be right for
Acute Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 202
Not applicableStudy completedNCT00005892
What this trial is testing

Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Myelodysplastic Syndrome and Acute Leukemia Related to Fanconi's Anemia

Who this might be right for
Fanconi's AnemiaMyelodysplastic SyndromesLeukemia, Nonlymphocytic, Acute+1 more
Fairview University Medical Center
Early research (Phase 1)Ended earlyNCT04755244
What this trial is testing

Evorpacept (ALX148) With Venetoclax and Azacitidine for Acute Myeloid Leukemia (ASPEN-05)

Who this might be right for
Acute Myeloid LeukemiaAML, Adult
ALX Oncology Inc. 14
Large-scale testing (Phase 3)Looking for participantsNCT03013998
What this trial is testing

Study of Biomarker-Based Treatment of Acute Myeloid Leukemia

Who this might be right for
Previously Untreated Relapsed Refractory Acute Myeloid Leukemia
Beat AML, LLC 3,000
Not applicableStudy completedNCT01233921
What this trial is testing

Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+86 more
Martin, Paul 6
Not applicableLooking for participantsNCT04777916
What this trial is testing

Prospective Non-interventional Study of Adult Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia (AML)
Acute Leukemia French Association 5,000
Not applicableLooking for participantsNCT06874257
What this trial is testing

Targeting Acute Myeloid Leukemia Immunosuppressive Microenvironment by combinedIDO1 Inhibition and PD-1 Blockade

Who this might be right for
AML (Acute Myelogenous Leukemia)
IRCCS Azienda Ospedaliero-Universitaria di Bologna 20
Large-scale testing (Phase 3)Looking for participantsNCT07232134
What this trial is testing

The Efficacy of Therapy in Patients With Acute Myeloid Leukemia and Down Syndrome in Russia

Who this might be right for
AML (Acute Myelogenous Leukemia)Down Syndrome (DS)
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 100
Early research (Phase 1)Ended earlyNCT03126864
What this trial is testing

Study of Adoptive Cellular Therapy Using Autologous T Cells Transduced With Lentivirus to Express a CD33 Specific Chimeric Antigen Receptor in Patients With Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia

Who this might be right for
Hematopoietic/Lymphoid CancerAcute Myeloid Leukemia
M.D. Anderson Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT00762632
What this trial is testing

Combination of Nilotinib (AMN107) and RAD001 in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Technical University of Munich 40
Testing effectiveness (Phase 2)Study completedNCT01700673
What this trial is testing

Phase II Study of Azacitidine and Sargramostim as Maintenance Treatment for Poor-Risk AML or MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 25
Not applicableNot Yet RecruitingNCT06022341
What this trial is testing

MultiOmic characteriZation of Acute Myeloid Leukemia Evolving From myelopRoliferative Neoplasm to Identify New Targeted Therapeutic Strategies

Who this might be right for
Myeloproliferative NeoplasmSecondary Leukemia
University Hospital, Angers 120
Testing effectiveness (Phase 2)Study completedNCT00001873
What this trial is testing

The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers

Who this might be right for
Chronic Lymphocytic LeukemiaGraft vs Host DiseaseHematologic Neoplasm+2 more
National Heart, Lung, and Blood Institute (NHLBI) 102
Testing effectiveness (Phase 2)Active Not RecruitingNCT04232241
What this trial is testing

Matched Unrelated vs. Haploidentical Donor for Allogeneic Stem Cell Transplantation in Patients With Acute Leukemia

Who this might be right for
Acute Myeloid Leukemia in RemissionAcute Lymphoblastic Leukemia in RemissionMyelodysplastic Syndromes
Universitätsklinikum Hamburg-Eppendorf 167
Not applicableStudy completedNCT01288222
What this trial is testing

Selecting a Favorable KIR Donor in Unrelated HCT for AML

Who this might be right for
Acute Myelogenous Leukemia
Masonic Cancer Center, University of Minnesota 506
Early research (Phase 1)Study completedNCT02367456
What this trial is testing

A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients

Who this might be right for
Myelodysplastic SyndromeAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia
Pfizer 73
Testing effectiveness (Phase 2)Active Not RecruitingNCT04231851
What this trial is testing

CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia

Who this might be right for
Acute Myelogenous Leukemia (AML) Due to TherapyAcute Myeloid Leukemia With Myelodysplasia-Related Changes
University of California, Irvine 30
Large-scale testing (Phase 3)Study completedNCT02140242
What this trial is testing

Comparison Between Two Dose Levels of Daunorubicin and Between One vs. Two Induction Cycles for Adult Patients With AML

Who this might be right for
Leukemia, Myelocytic, Acute
Technische Universität Dresden 721
Early research (Phase 1)Study completedNCT02270788
What this trial is testing

Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia
St. Jude Children's Research Hospital 10
Testing effectiveness (Phase 2)UnknownNCT00887042
What this trial is testing

Study of Reduced Toxicity Myeloablative Conditioning Regimen for Cord Blood Transplantation in Pediatric AML

Who this might be right for
Acute Myeloid Leukemia
The Korean Society of Pediatric Hematology Oncology 35
Next Page